Skip to content
Application 065200
- Type
- ANDA
- Sponsor
- CHARTWELL RX
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | GRISEOFULVIN | GRISEOFULVIN, MICROSIZE | SUSPENSION;ORAL | 125MG/5ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 62135-968 | Griseofulvin | Griseofulvin (microsize) | Chartwell RX, LLC. | ANDA | Current |
| 62135-968 | Griseofulvin | Griseofulvin (microsize) | Chartwell RX, LLC. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 42813 | ORIG | 2008-07-31 |